236 related articles for article (PubMed ID: 18221302)
1. HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
Ruys TA; Nanlohy NM; van den Berg CH; Hassink E; Beld M; van de Laar T; Bruisten S; Wit F; Krol A; Prins M; Lange J; van Baarle D
J Viral Hepat; 2008 Jun; 15(6):409-20. PubMed ID: 18221302
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
4. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
[TBL] [Abstract][Full Text] [Related]
6. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
[TBL] [Abstract][Full Text] [Related]
7. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
[TBL] [Abstract][Full Text] [Related]
8. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
Semmo N; Krashias G; Willberg C; Klenerman P
J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
11. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.
Wertheimer AM; Miner C; Lewinsohn DM; Sasaki AW; Kaufman E; Rosen HR
Hepatology; 2003 Mar; 37(3):577-89. PubMed ID: 12601356
[TBL] [Abstract][Full Text] [Related]
12. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
[TBL] [Abstract][Full Text] [Related]
13. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.
Barnes E; Harcourt G; Brown D; Lucas M; Phillips R; Dusheiko G; Klenerman P
Hepatology; 2002 Sep; 36(3):743-54. PubMed ID: 12198669
[TBL] [Abstract][Full Text] [Related]
14. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
[TBL] [Abstract][Full Text] [Related]
17. Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection.
Bes M; Sauleda S; Casamitjana N; Piron M; Campos-Varela I; Quer J; Cubero M; Puig L; Guardia J; Esteban JI
J Viral Hepat; 2012 Apr; 19(4):283-94. PubMed ID: 22404727
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
Mueller M; Spangenberg HC; Kersting N; Altay T; Blum HE; Klenerman P; Thimme R; Semmo N
J Hepatol; 2010 Jun; 52(6):800-11. PubMed ID: 20416967
[TBL] [Abstract][Full Text] [Related]
19. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
